SCHEMBL20346683

SCHEMBL20346683

Cc1ccc2c(=O)c3c(ccc4cc5c(cc43)OCO5)oc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.42
▸ HPGD P15428 6/20 0.42
▸ BCL2L1 Q07817 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ BAK1 Q16611 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.38
▸ HTT P42858 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ USP2 O75604 2/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ TSHR P16473 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20346686 0.91 ALPG (0.41) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20346674 0.86 ALDH1A1 (0.40) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20346763 0.84 ALDH1A1 (0.42) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20346708 0.84 PDE5A (0.42) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20349998 0.84 CYP3A4 (0.55) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL20346621 0.82 MEN1 (0.52) ALDH1A1HPGDKDM4EHTTHSD17B10
SCHEMBL20349988 0.81 PIM1 (0.44) ALDH1A1BCL2L1MCL1BAK1CYP1A2
SCHEMBL20346685 0.79 PDE10A (0.40) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20346751 0.78 KDM4E (0.40) ALDH1A1HPGDBCL2L1MCL1BAK1
SCHEMBL20346718 0.77 PDE5A (0.43) BCL2L1MCL1BAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, NR1H2, NR1H3 ALDH1A1 1200/4885HPGD 303/4885BCL2L1 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback